Status:
COMPLETED
Assessment of Prepulse Inhibition for Shock Pain Reduction
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Dr. Douglas Cameron
Abbott Medical Devices
Conditions:
Pain Awareness From ICD Shocks
Eligibility:
All Genders
18-88 years
Phase:
NA
Brief Summary
Patient tolerance of pain from discharges of implantable cardioverter defibrillators (ICD's) is highly variable. It can be influenced by psychological factors, physical condition and the number of sho...
Eligibility Criteria
Inclusion
- 18+ Approved indication for implantation of an ICD Able and willing to provide informed consent Independently complete and understand the Mini Mental State Evaluation
Exclusion
- Pregnancy Cannot understand English or French Contraindicated for defibrillation testing because of risk of thromboembolism Deaf or hard of hearing, making the acute testing difficult to conduct having pain or anxiety to the extent that, in the opinion of the investigator, the results would be confounded.
- Having a Class I bradycardia pacing indication, requiring ongoing pacing support.
- Visual problems which preclude reading the computer screen for the VAS test Severe musculoskeletal disorder that makes it difficult to undergo testing in the recumbent position Do not achieve a score \>24/30 on a Mini Mental State Exam
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00193986
Start Date
May 1 2005
End Date
June 1 2005
Last Update
November 14 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4